|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/40 | |
| A61K 38/25 | |||
| A61K 9/19 |
| (11) | Number of the document | 2961432 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14756414.0 |
| Date of filing the European patent application | 2014-02-26 | |
| (97) | Date of publication of the European application | 2016-01-06 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CA2014/050134 |
| Date | 2014-02-26 |
| (87) | Number | WO 2014/131122 |
| Date | 2014-09-04 |
| (30) | Number | Date | Country code |
| 201361771244 P | 2013-03-01 | US | |
| 201313803712 | 2013-03-14 | US |
| (72) |
SHINGEL, Kirill, CA
FLEURY, Daniel, CA
|
| (73) |
THERATECHNOLOGIES INC.,
2015 Peel Street, 5th Floor, Montreal, QC H3A 1T8,
CA
|
| (54) | FORMULATIONS OF GROWTH HORMONE RELEASING FACTOR (GRF) MOLECULES WITH IMPROVED STABILITY |
| FORMULATIONS OF GROWTH HORMONE RELEASING FACTOR (GRF) MOLECULES WITH IMPROVED STABILITY |